text:
Journal entry
From Wikipedia, the free encyclopedia
Jump to: navigation, search
This article possibly contains original research. Please improve it by verifying the claims made and adding inline citations. Statements consisting only of original research should be removed. (November 2017) (Learn how and when to remove this template message)
This article does not cite any sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (November 2017) (Learn how and when to remove this template message)
Journal entries are an important part of accountancy. A journal entry, in accounting, is the logging of a transaction into accounting journal items. The journal entry can consist of several recordings, each of which is either a debit or a credit. The total of the debits must equal the total of the credits or the journal entry is said to be "unbalanced". Journal entries can record unique items or recurring items such as depreciation or bond amortization. In accounting software, journal entries are usually entered using a separate module from accounts payable, which typically has its own subledger that indirectly affects the general ledger. As a result, journal entries directly change the account balances on the general ledger.
Contents
[hide]
1 Recording
2 Type of accounts
3 See also
4 References
Recording[edit]
In order to record journal entries, one needs to have knowledge about:
Type of Accounts
Golden Rules of Accounting
Experience of Working
Type of accounts[edit]
There are three type of accounts in accounting:
Personal account
Real account
Nominal account
Nominal accountNominal accountNominal accountNominal account
Personal accounts consist of all those accounts which are related to a person, business, firm etc. There are also subtypes of personal account:
Natural Personal Any person like Mohan Account, Ram account etc.
Artificial Personal Any company or group of people like Microsoft account, Hindustan Petroleum account etc
Representative Personal this type of Personal a/c represents owner like. Capital a/c, drawings a/c etc
For example: Mohan's account, Apple ltd. account etc. Capital account
Real accounts consist of all those accounts which are related to assets.
For example: Plant and Machinery account, Stock account etc.
Nominal accounts consist of all those accounts which are related to expenses, losses, Income and Gains.
For example: Rent account, wages account etc.
See also[edit]
Double-entry bookkeeping system
Trial balance
Debits and credits
References[edit]
Retrieved from "https://en.wikipedia.org/w/index.php?title=Journal_entry&oldid=836237230"
Categories:
Accounting journals and ledgers
Hidden categories:
Articles that may contain original research from November 2017
All articles that may contain original research
Articles lacking sources from November 2017
All articles lacking sources
Navigation menu
Personal tools
Not logged in
Talk
Contributions
Create account
Log in
Namespaces
Article
Talk
Variants
Views
Read
Edit
View history
More
Search
Navigation
Main page
Contents
Featured content
Current events
Random article
Donate to Wikipedia
Wikipedia store
Interaction
Help
About Wikipedia
Community portal
Recent changes
Contact page
Tools
What links here
Related changes
Upload file
Special pages
Permanent link
Page information
Wikidata item
Cite this page
Print/export
Create a book
Download as PDF
Printable version
Languages
Nederlands
Tiếng Việt
中文
Edit links
This page was last edited on 13 April 2018, at 14:35.
Text is available under the Creative Commons Attribution-ShareAlike License; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.
Privacy policy
About Wikipedia
Disclaimers
Contact Wikipedia
Developers
Cookie statement
Mobile view
Enable previews

key: html

type: local

value: div

attrs: id class

values: mw-page-base noprint

values: mw-head-base noprint

value: a

attrs: id class lang

values: firstHeading firstHeading en

values: siteSub noprint

values: jump-to-nav mw-jump

attrs: alt src width height srcset data-file-width data-file-height

value: td

attrs: href title

value: b

value: span

value: i

value: small

value: tr

values: plainlinks metadata ambox ambox-content ambox-Original_research

values: Help:Introduction to referencing with Wiki Markup/1

values: plainlinks metadata ambox ambox-content ambox-Unreferenced

values:
/wiki/Specialized_journals
mw-redirect
Specialized journals

values:
/wiki/Debit_(accounting)
mw-redirect
Debit (accounting)

values:
/wiki/Credit_(accounting)
mw-redirect
Credit (accounting)

values: Category:Accounting journals and ledgers

values: Category:Articles that may contain original research from November 2017

values: Category:All articles that may contain original research

values: Category:Articles lacking sources from November 2017

values: Discussion about edits from this IP address [ctrl-alt-n]

values: A list of edits made from this IP address [ctrl-alt-y]

values: You are encouraged to create an account and log in; however, it is not mandatory

values: You're encouraged to log in; however, it's not mandatory. [ctrl-alt-o]

values:
/wiki/Journal_entry
View the content page [ctrl-alt-c]
c

values: Discussion about the content page [ctrl-alt-t]

values: p-namespaces navigation vectorTabs p-namespaces-label

values:
p-variants
navigation
vectorMenu emptyPortlet
p-variants-label

values: Past revisions of this page [ctrl-alt-h]

values: p-views navigation vectorTabs p-views-label

values:
p-cactions
navigation
vectorMenu emptyPortlet
p-cactions-label

values:
mw-wiki-logo
/wiki/Main_Page
Visit the main page

values:
/wiki/Main_Page
Visit the main page [ctrl-alt-z]
z

values: Featured content – the best of Wikipedia

values: Find background information on current events

values:
/wiki/Special:Random
Load a random article [ctrl-alt-x]
x

values: portal navigation p-navigation p-navigation-label

values: Guidance on how to use and edit Wikipedia

values: About the project, what you can do, where to find things

values: A list of recent changes in the wiki [ctrl-alt-r]

values: portal navigation p-interaction p-interaction-label

values: List of all English Wikipedia pages containing links to this page [ctrl-alt-j]

values: Recent changes in pages linked from this page [ctrl-alt-k]

values:
/wiki/Wikipedia:File_Upload_Wizard
Upload files [ctrl-alt-u]
u

values: A list of all special pages [ctrl-alt-q]

values: Permanent link to this revision of the page

values: Link to connected data repository item [ctrl-alt-g]

values: Printable version of this page [ctrl-alt-p]

values:
suggestions
display: none; font-size: 13px;

values: mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject page-Journal_entry rootpage-Journal_entry skin-vector action-view


text:
How Ya Gonna Keep 'em Down on the Farm (After They've Seen Paree)?
From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
"How Ya Gonna Keep 'em Down on the Farm (After They've Seen Paree)?"
Sheet music cover
Song
Published
1919
Composer(s)
Walter Donaldson
Lyricist(s)
Joe Young, Sam M. Lewis
"How Ya Gonna Keep 'em Down on the Farm (After They've Seen Paree?)" is a World War I song that rose to popularity after the war had ended. The lyrics highlight concern that American soldiers from rural environments would not want to return to farm life after experiencing the European city life and culture of Paris during World War I.
Contents
[hide]
1 Performances and recordings
2 Composition
3 References
3.1 Bibliography
4 External links
Performances and recordings[edit]
The song was first introduced to vaudeville by Sophie Tucker.[1]
Eddie Cantor also added it to his stage set.[1]
In 1919, an early jazz band, Jim Europe's 369th Infantry Band frequently performed this song in 1919 after arriving back in New York.[2] They recorded a version for Pathé Records and it became a hit for that year.[3]
Also, Nora Bayes and Billy Murray recorded it for Columbia that same year. Bayes' version reached number two on the US song charts in March 1919.[3] Victor released its recording, featuring the singer Arthur Fields, on February 27, 1919.[4]
Like many World War I songs, it was sung by soldiers in World War II.[5]
Andrew Bird included a more melancholy cover version in his 2007 EP Soldier On. In The Lego Movie (2014), the song is briefly sung in Judy Garland's voice by the character Metalbeard (using a sample from the 1942 film For Me and My Gal).
Composition[edit]
The song features music by Walter Donaldson and words by Joe Young and Sam M. Lewis. It was published in 1919 by Waterson, Berlin & Snyder Co in New York.[6] The team of Donaldson, Young and Lewis, wrote another topical song commenting on soldiers returning from the war that was released by Victor the day before "How Ya Gonna Keep Em Down on the Farm." "Don’t Cry Frenchy, Don’t Cry" was released by Victor on February 26, 1919. It featured the singers Charles Hart and Elliott Shaw.[7][8]
The song is in the public domain.
References[edit]
^ Jump up to: a b Holsinger, M. Paul, "How Ya Gonna Keep 'Em Down on the Farm?" (Song), War and American Popular Culture: A Historical Encyclopedia. Edited by M Paul Holsinger, Westport, CT: Greenwood Press, 1999, ISBN 0313299080, p.207.
Jump up ^ Hagedorn, Ann. Savage Peace: Hope and Fear in America, 1919. New York: Simon & Schuster, 2007, ISBN 9780743243711, p. 99-101.
^ Jump up to: a b Top Songs of 1919 ••• Music VF, US & UK hits charts. Musicvf.com. Retrieved on 2014-07-07.
Jump up ^ http://www.78discography.com/vic18500.html retrieved February 16, 2015
Jump up ^ True, William, and Deryck Tufts True. The Cow Spoke French: The Story of Sgt. William True, American Paratrooper in World War II. Bennington, Vt: Merriam Press, 2002, ISBN 1576382966, p. 255.
Jump up ^ Donaldson, Wallter (1919). How 'Ya Gonna Keep 'em Down on the Farm (After They've Seen Paree?). New York, NY: Waterson, Berlin & Snyder. OCLC 20267380.
Jump up ^ https://www.loc.gov/jukebox/recordings/detail/id/7000/ retrieved February 16, 2015
Jump up ^ http://www.78discography.com/vic18500.html retrieved 2/16/2915
Bibliography[edit]
Hagedorn, Ann. Savage Peace: Hope and Fear in America, 1919. New York: Simon & Schuster, 2007. ISBN 9780743243711
Holsinger, M. Paul, "How Ya Gonna Keep 'Em Down on the Farm?" (Song) in War and American Popular Culture: A Historical Encyclopedia. Edited by M Paul Holsinger, Westport, CT: Greenwood Press, 1999. ISBN 0313299080
True, William, and Deryck Tufts True. The Cow Spoke French: The Story of Sgt. William True, American Paratrooper in World War II. Bennington, Vt: Merriam Press, 2002. ISBN 1576382966
External links[edit]
Listen to an MP3 of the song and see the sheet music at the Illinois Digital Arcihve
How 'ya gonna keep 'em down on the farm : (after they've seen Paree?) Sheet Music at the Library of Congress
Discography of American Historical Recordings
Retrieved from "https://en.wikipedia.org/w/index.php?title=How_Ya_Gonna_Keep_%27em_Down_on_the_Farm_(After_They%27ve_Seen_Paree)%3F&oldid=839160383"
Categories:
Songs of World War I
1919 songs
Nora Bayes songs
Billy Murray (singer) songs
Songs with music by Walter Donaldson
Songs with lyrics by Joe Young (lyricist)
Songs with lyrics by Sam M. Lewis
Navigation menu
Personal tools
Not logged in
Talk
Contributions
Create account
Log in
Namespaces
Article
Talk
Variants
Views
Read
Edit
View history
More
Search
Navigation
Main page
Contents
Featured content
Current events
Random article
Donate to Wikipedia
Wikipedia store
Interaction
Help
About Wikipedia
Community portal
Recent changes
Contact page
Tools
What links here
Related changes
Upload file
Special pages
Permanent link
Page information
Wikidata item
Cite this page
Print/export
Create a book
Download as PDF
Printable version
Languages
Deutsch
Edit links
This page was last edited on 1 May 2018, at 17:25.
Text is available under the Creative Commons Attribution-ShareAlike License; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.
Privacy policy
About Wikipedia
Disclaimers
Contact Wikipedia
Developers
Cookie statement
Mobile view
Enable previews

values: mw-page-base noprint

values: mw-head-base noprint

values: firstHeading firstHeading en

values: siteSub noprint

attrs: class href

values: mw-jump-link #mw-head

values: mw-jump-link #p-search

value: th

attrs: colspan class style

value: img

values: How 'ya gonna keep 'em down on the farm (After they've seen Paree) (SM-2-073).jpg

attrs: href class

attrs: colspan style

values: Edit section: Performances and recordings

values:
nofollow
external text
http://www.musicvf.com/1919.year

values:
nofollow
external text
//www.worldcat.org/oclc/20267380

values:
reflist mw-references-wrap
list-style-type: decimal;

values:
nofollow
external text
https://www.loc.gov/item/ihas.200201432

values: Category:Songs with music by Walter Donaldson

values: Category:Songs with lyrics by Joe Young (lyricist)

values: Category:Songs with lyrics by Sam M. Lewis

values:
catlinks mw-normal-catlinks
catlinks mw-normal-catlinks
interface

values: Discussion about edits from this IP address [ctrl-alt-n]

values: A list of edits made from this IP address [ctrl-alt-y]

values: You are encouraged to create an account and log in; however, it is not mandatory

values: You're encouraged to log in; however, it's not mandatory. [ctrl-alt-o]

values: Discussion about the content page [ctrl-alt-t]

values: p-namespaces navigation vectorTabs p-namespaces-label

values:
p-variants
navigation
vectorMenu emptyPortlet
p-variants-label

values: Past revisions of this page [ctrl-alt-h]

values: p-views navigation vectorTabs p-views-label

values:
p-cactions
navigation
vectorMenu emptyPortlet
p-cactions-label

values:
mw-wiki-logo
/wiki/Main_Page
Visit the main page

values:
/wiki/Main_Page
Visit the main page [ctrl-alt-z]
z

values: Featured content – the best of Wikipedia

values: How Ya Gonna Keep ’Em Down on the Farm? – German

values: /static/images/wikimedia-button-1.5x.png 1.5x, /static/images/wikimedia-button-2x.png 2x

values: /static/images/poweredby_mediawiki_132x47.png 1.5x, /static/images/poweredby_mediawiki_176x62.png 2x

values: mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject page-How_Ya_Gonna_Keep_em_Down_on_the_Farm_After_They_ve_Seen_Paree rootpage-How_Ya_Gonna_Keep_em_Down_on_the_Farm_After_They_ve_Seen_Paree skin-vector action-view


text:
Leprosy
From Wikipedia, the free encyclopedia
Jump to: navigation, search
For the Biblical term and its varied meanings, see Tzaraath. For other uses, see Leprosy (disambiguation).
"Leper" redirects here. It is not to be confused with Ieper, a Belgian city.
Leprosy
Synonyms
Hansen's disease (HD)
A 24-year-old man with leprosy (1886)
Pronunciation
/ˈlɛprəsi/[1]
Specialty
Infectious disease
Symptoms
Decreased ability to feel pain[2]
Causes
Mycobacterium leprae or Mycobacterium lepromatosis[3][4]
Risk factors
Close contact with a case of leprosy, living in poverty[2][5]
Treatment
Multidrug therapy[3]
Medication
Rifampicin, dapsone, clofazimine[2]
Frequency
514,000 (2015)[6]
Leprosy, also known as Hansen's disease (HD), is a long-term infection by the bacterium Mycobacterium leprae or Mycobacterium lepromatosis.[3][4] Initially, infections are without symptoms and typically remain this way for 5 to 20 years.[3] Symptoms that develop include granulomas of the nerves, respiratory tract, skin, and eyes.[3] This may result in a lack of ability to feel pain, thus loss of parts of extremities due to repeated injuries or infection due to unnoticed wounds.[2] Weakness and poor eyesight may also be present.[2]
Leprosy is spread between people.[7] This is thought to occur through a cough or contact with fluid from the nose of an infected person.[7] Leprosy occurs more commonly among those living in poverty.[2] Contrary to popular belief, it is not highly contagious.[2] The two main types of disease are based on the number of bacteria present: paucibacillary and multibacillary.[2] The two types are differentiated by the number of poorly pigmented, numb skin patches present, with paucibacillary having five or fewer and multibacillary having more than five.[2] The diagnosis is confirmed by finding acid-fast bacilli in a biopsy of the skin or by detecting the DNA using polymerase chain reaction.[2]
Leprosy is curable with a treatment known as multidrug therapy.[3] Treatment for paucibacillary leprosy is with the medications dapsone and rifampicin for six months.[2] Treatment for multibacillary leprosy consists of rifampicin, dapsone, and clofazimine for 12 months.[2] A number of other antibiotics may also be used.[2] These treatments are provided free of charge by the World Health Organization.[3] Globally in 2012, the number of chronic cases of leprosy was 189,000, down from some 5.2 million in the 1980s.[3][8][9] The number of new cases was 230,000.[3] Most new cases occur in 16 countries, with India accounting for more than half.[3][2] In the past 20 years, 16 million people worldwide have been cured of leprosy.[3] About 200 cases are reported per year in the United States.[10]
Leprosy has affected humanity for thousands of years.[2] The disease takes its name from the Greek word lepra, while the term "Hansen's disease" is named after the Norwegian physician Gerhard Armauer Hansen.[2] Separating people by placing them in leper colonies still occurs in places such as India,[11] China,[12] and Africa.[13] However, most colonies have closed, since leprosy is not very contagious.[13] Social stigma has been associated with leprosy for much of history, which continues to be a barrier to self-reporting and early treatment.[3] Some consider the word "leper" offensive, preferring the phrase "person affected with leprosy".[14] It is classified as a neglected tropical disease.[15] World Leprosy Day was started in 1954 to draw awareness to those affected by leprosy.[16]
Contents
[hide]
1 Signs and symptoms
2 Cause
2.1 M. leprae and M. lepromatosis
2.2 Risk factors
2.3 Transmission
2.4 Genetics
3 Pathophysiology
4 Diagnosis
4.1 Classification
5 Prevention
6 Treatment
7 Epidemiology
7.1 Disease burden
8 History
9 Society and culture
9.1 India
9.2 Treatment cost
9.3 Historical texts
9.4 Middle Ages
9.5 19th century
9.5.1 Norway
9.5.2 Colonialism and imperialism
9.6 Stigma
9.7 Programs and treatment
9.8 Notable cases
10 Other animals
11 See also
12 References
13 External links
Signs and symptoms[edit]
Leprosy is mostly a granulomatous disease of the peripheral nerves and mucosa of the upper respiratory tract; skin lesions (light or dark patches) are the primary external sign.[17] If untreated, leprosy can progress and cause permanent damage to the skin, nerves, limbs, and eyes.[18][19] Secondary infections, in turn, can result in tissue loss, causing fingers and toes to become shortened and deformed, as cartilage is absorbed into the body.[18][19][20]
Hands deformed by leprosy
Leprosy in Tahiti, circa 1895
A 26-year-old woman with leprous lesions
A 13-year-old boy with severe leprosy
Cause[edit]
M. leprae and M. lepromatosis[edit]
M. leprae, one of the causative agents of leprosy: As an acid-fast bacterium, M. leprae appears red when a Ziehl-Neelsen stain is used.
Main articles: Mycobacterium leprae and Mycobacterium lepromatosis
M. leprae and M. lepromatosis are the causative agents of leprosy. M. lepromatosis is a relatively newly identified mycobacterium isolated from a fatal case of diffuse lepromatous leprosy in 2008.[4][17]
An intracellular, acid-fast bacterium, M. leprae is aerobic and rod-shaped, and is surrounded by the waxy cell membrane coating characteristic of the Mycobacterium genus.[21]
Due to extensive loss of genes necessary for independent growth, M. leprae and M. lepromatosis are obligate intracellular pathogens, and unculturable in the laboratory, a factor that leads to difficulty in definitively identifying the organism under a strict interpretation of Koch's postulates.[4][22] The use of nonculture-based techniques such as molecular genetics has allowed for alternative establishment of causation.
While the causative organisms have to date been impossible to culture in vitro, it has been possible to grow them in animals such as mice and armadillos.
Naturally occurring infection also has been reported in nonhuman primates, including the African chimpanzee, sooty mangabey, and cynomolgus macaque, as well as in armadillos and red squirrels.[23]
Red squirrels (Sciurus vulgaris) - a threatened species - in England were found to have leprosy in November 2016.[24] However, no squirrel cases have spread to a human for hundreds of years.[25]
Risk factors[edit]
The greatest risk factor for developing leprosy is contact with another case of leprosy. Contacts of people with leprosy are five to eight times more likely to develop leprosy than members of the general population.[5] Leprosy also occurs more commonly among those living in poverty.[2]
Other risk factors are poorly understood. However, conditions that reduce immune function, such as malnutrition, other illnesses, or host genetic differences, may increase the risk of developing leprosy.[5] Despite this, infection with HIV does not appear to increase the risk of developing leprosy.[26]
Transmission[edit]
Transmission of leprosy occurs during close contact with those who are infected.[27] Transmission is proposed to be by nasal droplets,[9][27] but many questions remain about its mode of transmission and epidemiology.[28]
Leprosy is not known to be either sexually transmitted or highly infectious. People are generally no longer infectious after the first month of standard multidrug therapy.[27]
Leprosy may also be transmitted to humans by armadillos.[29]
Two exit routes of M. leprae from the human body often described are the skin and the nasal mucosa, although their relative importance is not clear. Lepromatous cases show large numbers of organisms deep in the dermis, but whether they reach the skin surface in sufficient numbers is doubtful.[30]
The skin and the upper respiratory tract are most likely entry route. While older research dealt with the skin route, recent research has increasingly favored the respiratory route. Experimental transmission of leprosy through aerosols containing M. leprae in immunosuppressed mice was accomplished, suggesting a similar possibility in humans.[31]
Genetics[edit]
Name
Locus
OMIM
Gene
LPRS1 10p13 609888
LPRS2 6q25 607572 PARK2, PACRG
LPRS3 4q32 246300 TLR2
LPRS4 6p21.3 610988 LTA
LPRS5 4p14 613223 TLR1
LPRS6 13q14.11 613407
Several genes have been associated with a susceptibility to leprosy. Often, the immune system is able to eliminate leprosy during the early infection stage before severe symptoms develop.[32] A defect in cell-mediated immunity may cause susceptibility to leprosy. The region of DNA responsible for this variability is also involved in Parkinson's disease, giving rise to current speculation that the two disorders may be linked in some way at the biochemical level.[33] Some evidence indicates not all people who are infected with M. leprae develop leprosy, and genetic factors have long been thought to play a role, due to the observation of clustering of leprosy around certain families, and the failure to understand why certain individuals develop lepromatous leprosy while others develop other types of leprosy.[34]
Pathophysiology[edit]
How the infection produces the symptoms of the disease is not known.[9]
Diagnosis[edit]
According to the World Health Organization, diagnosis in areas where people are frequently infected is based on one of these main signs:
Skin lesion consistent with leprosy and with definite sensory loss
Positive skin smears
Skin lesions can be single or multiple, and usually hypopigmented, although occasionally reddish or copper-colored. The lesions may be macules (flat), papules (raised), or nodular. The sensory loss at the skin lesion is important because this feature can help differentiate it from other causes of skin lesions such as tinea versicolor. Thickened nerves are associated with leprosy and can be accompanied by loss of sensation or muscle weakness. However, without the characteristic skin lesion and sensory loss, muscle weakness is not considered a reliable sign of leprosy.
In some cases, acid-fast leprosy bacilli in skin smears are considered diagnostic; however, the diagnosis is clinical.[35]
Diagnosis in areas where the disease is uncommon, such as the United States, is often delayed because healthcare providers are unaware of leprosy and its symptoms. Early diagnosis and treatment prevent nerve involvement, the hallmark of leprosy, and the disability it causes.[36]
Many kinds of leprosy are known, but some symptoms are common to them, including runny nose, dry scalp, eye problems, skin lesions, muscle weakness, reddish skin, smooth, shiny, diffuse thickening of facial skin, ear, and hand, loss of sensation in fingers and toes, thickening of peripheral nerves, and flat nose due to destruction of nasal cartilage. Also, phonation and resonation of sound occur during speech. Often, atrophy of the testes with resulting impotence occurs.
Classification[edit]
Several different approaches for classifying leprosy exist, but parallels exist.
The World Health Organization system distinguishes "paucibacillary" and "multibacillary" based upon the proliferation of bacteria.[37]("pauci-" refers to a low quantity.)
The Ridley-Jopling scale provides five gradations.[38][39]
The ICD-10, though developed by the WHO, uses Ridley-Jopling and not the WHO system. It also adds an indeterminate ("I") entry.[30]
In MeSH, three groupings are used.
WHO
Ridley-Jopling
ICD-10
MeSH
Description
Lepromin test
Paucibacillary tuberculoid ("TT"),
borderline
tuberculoid ("BT") A30.1, A30.2 Tuberculoid It is characterized by one or more hypopigmented skin macules and patches where skin sensations are lost because of damaged peripheral nerves that have been attacked by the human host's immune cells. Positive
Multibacillary midborderline
or
borderline ("BB") A30.3 Borderline Borderline leprosy is of intermediate severity and is the most common form. Skin lesions resemble tuberculoid leprosy, but are more numerous and irregular; large patches may affect a whole limb, and peripheral nerve involvement with weakness and loss of sensation is common. This type is unstable and may become more like lepromatous leprosy or may undergo a reversal reaction, becoming more like the tuberculoid form.
Multibacillary borderline lepromatous ("BL"),
and lepromatous ("LL") A30.4, A30.5 Lepromatous It is associated with symmetric skin lesions, nodules, plaques, thickened dermis, and frequent involvement of the nasal mucosa resulting in nasal congestion and nose bleeds, but, typically, detectable nerve damage is late. Negative
A difference in immune response to the tuberculoid and lepromatous forms is seen.[40]
Leprosy may also be divided into:[41]:344–346
Early and indeterminate leprosy
Tuberculoid leprosy
Borderline tuberculoid leprosy
Borderline leprosy
Borderline lepromatous leprosy
Lepromatous leprosy
Histoid leprosy
Diffuse leprosy of Lucio and Latapí
This disease may also occur with only neural involvement, without skin lesions.[27][42][43][44][45][46]
Prevention[edit]
Early detection of the disease is important, since physical and neurological damage may be irreversible even if cured. Medications can decrease the risk of those living with people with leprosy from acquiring the disease and likely those with whom people with leprosy come into contact outside the home.[47] However, concerns are known of resistance, cost, and disclosure of a person's infection status when doing follow-up of contacts. Therefore, the WHO recommends that people who live in the same household be examined for leprosy and be treated only if symptoms are present.[47]
The Bacillus Calmette–Guérin (BCG) vaccine offers a variable amount of protection against leprosy in addition to its target of tuberculosis.[48] It appears to be 26 to 41% effective (based on controlled trials) and about 60% effective based on observational studies with two doses possibly working better than one.[49][50] Development of a more effective vaccine is ongoing.[47][51][52][53]
Treatment[edit]
MDT antileprosy drugs: standard regimens
A number of leprostatic agents are available for treatment. For paucibacillary (PB or tuberculoid) cases, treatment with daily dapsone and monthly rifampicin for six months is recommended,[2] while for multibacillary (MB or lepromatous) cases, treatment with daily dapsone and clofazimine along with monthly rifampicin for 12 months is recommended.[2]
Multidrug therapy (MDT) remains highly effective, and people are no longer infectious after the first monthly dose.[27] It is safe and easy to use under field conditions due to its presentation in calendar blister packs.[27] Relapse rates remain low, and no resistance to the combined drugs is seen.[27]
Epidemiology[edit]
Main article: Epidemiology of leprosy
World distribution of leprosy, 2003
Disability-adjusted life year for leprosy per 100,000 inhabitants in 2004[54]
no data
<1.5
1.5–3
3–4.5
4.5–6
6–7.5
7.5–9
9–10.5
10.5–12
12–13.5
13.5–15
15–20
>20
In 2015, the number of cases of leprosy was about 175,000 and the number of new cases was 210,000.[55]
As of 2013, 14 countries contain 95% of the globally reported leprosy cases.[56] Of these, India has the greatest number of cases (59%), followed by Brazil (14%) and Indonesia (8%).[56] Although the number of cases worldwide continues to fall, pockets of high prevalence remain in certain areas such as Brazil, South Asia (India, Nepal, Bhutan), some parts of Africa (Tanzania, Madagascar, Mozambique), and the western Pacific.
The number of cases of leprosy was in the tens of millions in the 1960s; a series of national (the International Federation of Anti-Leprosy Associations) and international (the WHO's "Global Strategy for Reducing Disease Burden Due to Leprosy") initiatives have reduced the total number and the number of new cases of the disease.[9][57] In 1995, two to three million people were estimated to be permanently disabled because of leprosy.[58]
Disease burden[edit]
Although the number of new leprosy cases occurring each year is important as a measure of transmission, it is difficult to measure due to leprosy's long incubation period, delays in diagnosis after onset of the disease, and the lack of laboratory tools to detect it in the very early stages. Instead, the registered prevalence is used. Registered prevalence is a useful proxy indicator of the disease burden, as it reflects the number of active leprosy cases diagnosed with the disease and receiving treatment with MDT at a given point in time. The prevalence rate is defined as the number of cases registered for MDT treatment among the population in which the cases have occurred, again at a given point in time.[59]
New case detection is another indicator of the disease that is usually reported by countries on an annual basis. It includes cases diagnosed with the onset of disease in the year in question (true incidence) and a large proportion of cases with onset in previous years (termed a backlog prevalence of undetected cases).
Endemic countries also report the number of new cases with established disabilities at the time of detection, as an indicator of the backlog prevalence. Determination of the time of onset of the disease is, in general, unreliable, is very labor-intensive, and is seldom done in recording these statistics.
History[edit]
Main article: History of leprosy
G. H. A. Hansen, discoverer of M. leprae
Using comparative genomics, in 2005, geneticists traced the origins and worldwide distribution of leprosy from East Africa or the Near East along human migration routes. They found four strains of M. leprae with specific regional locations. Strain 1 occurs predominantly in Asia, the Pacific region, and East Africa; strain 4, in West Africa and the Caribbean; strain 3 in Europe, North Africa, and the Americas; and strain 2 only in Ethiopia, Malawi, Nepal/north India, and New Caledonia.
On the basis of this, they offer a map of the dissemination of leprosy in the world. This confirms the spread of the disease along the migration, colonisation, and slave trade routes taken from East Africa to India, West Africa to the New World, and from Africa into Europe and vice versa.[60]
The oldest skeletal evidence for the disease date from 2000 BCE, as found in human remains from the archaeological sites of Balathal in India and Harappa in Pakistan.[61][62]
Although retrospectively identifying descriptions of leprosy-like symptoms is difficult, what appears to be leprosy was discussed by Hippocrates in 460 BC. In 1846, Francis Adams produced The Seven Books of Paulus Aegineta which included a commentary on all medical and surgical knowledge and descriptions and remedies to do with leprosy from the Romans, Greeks, and Arabs.[63]
Interpretations of the presence of leprosy have been made on the basis of descriptions in ancient Indian (Atharva Veda and Kausika Sutra), Greek, and Middle Eastern documentary sources that describe skin afflictions.[64]
Skeletal remains from the second millennium BC, discovered in 2009, represent the oldest documented evidence for leprosy. Located at Balathal, in Rajasthan, northwest India, the discoverers suggest that if the disease did migrate from Africa to India, during the third millennium BC "at a time when there was substantial interaction among the Indus Civilization, Mesopotamia, and Egypt, there needs to be additional skeletal and molecular evidence of leprosy in India and Africa so as to confirm the African origin of the disease."[65] A proven human case was verified by DNA taken from the shrouded remains of a man discovered in a tomb next to the Old City of Jerusalem dated by radiocarbon methods to 1–50 AD.[66]
The causative agent of leprosy, M. leprae, was discovered by G. H. Armauer Hansen in Norway in 1873, making it the first bacterium to be identified as causing disease in humans.[67] The first effective treatment (promin) became available in the 1940s.[68] In the 1950s, dapsone was introduced. The search for further effective antileprosy drugs led to the use of clofazimine and rifampicin in the 1960s and 1970s.[69] Later, Indian scientist Shantaram Yawalkar and his colleagues formulated a combined therapy using rifampicin and dapsone, intended to mitigate bacterial resistance.[70] MDT combining all three drugs was first recommended by the WHO in 1981. These three antileprosy drugs are still used in the standard MDT regimens.
Leprosy was once believed to be highly contagious and was treated with mercury—as was syphilis, which was first described in 1530. Many early cases thought to be leprosy could actually have been syphilis.[71]
Resistance has developed to initial treatment. Until the introduction of MDT in the early 1980s, leprosy could not be diagnosed and treated successfully within the community.[72]
Japan still has sanatoriums (although Japan's sanatoriums no longer have active leprosy cases, nor are survivors held in them by law).[73]
The importance of the nasal mucosa in the transmission of M leprae was recognized as early as 1898 by Schäffer, in particular, that of the ulcerated mucosa.[74]
Society and culture[edit]
Two lepers denied entrance to town, 14th century
India[edit]
British India enacted the Leprosy Act of 1898 which institutionalized those affected and segregated them by gender to prevent reproduction. The Act was difficult to enforce but was repealed in 1983 only after MDT therapy had become widely available. In 1983, the National Leprosy Elimination Programme, previously the National Leprosy Control Programme, changed its methods from surveillance to the treatment of people with leprosy. India still accounts for over half of the global disease burden.[75]
Treatment cost[edit]
Between 1995 and 1999, the WHO, with the aid of the Nippon Foundation, supplied all endemic countries with free MDT in blister packs, channeled through ministries of health. This free provision was extended in 2000 and again in 2005, 2010 and 2015 with donations by the MDT manufacturer Novartis through the WHO. In the latest agreement signed between the company and the WHO in October 2015, the provision of free MDT by the WHO to all endemic countries will run until the end of 2020. At the national level, nongovernment organizations affiliated with the national program will continue to be provided with an appropriate free supply of this WHO-supplied MDT by the government.
Historical texts[edit]
Written accounts of leprosy date back thousands of years. Various skin diseases translated as leprosy appear in the ancient Indian text, the Atharava Veda, as early as 2000 BC. Another Indian text, the Laws of Manu (1500 BC), prohibited contact with those infected with the disease and made marriage to a person infected with leprosy punishable.[76]
Biblically speaking, the Hebraic root tsara or tsaraath (צָרַע, --tsaw-rah' -- to be struck with leprosy, to be leprous) and the Greek (λεπρός - lepros), are of broader classification than the more narrow use of the term related to Hansen's Disease. Any progressive skin disease (a whitening or splotchy bleaching of skin, raised manifestations of scales, scabs, infections, rashes, etc.…) as well as generalized molds and surface discoloration of any clothing, leather, and/or discoloration on walls surfaces throughout homes all came under the "law of leprosy" (Leviticus 14:54-57).[77] Ancient sources also such as the Talmud (Sifra 63) make clear that tzaraath refers to various types of lesions or stains associated with ritual impurity and occurring on cloth, leather, or houses, as well as skin. It may sometimes be a symptom of the disease described in this article but has many other causes, as well. The New Testament describes instances of Jesus healing people with leprosy (Luke 5:10), although the precise relationship between this, tzaraath, and Hansen's disease is not established.
The biblical perception that people with leprosy were unclean may be connected to a passage from Leviticus 13: 44-46, among others. Judeo-Christian belief, for some, held that leprosy was of moral consequence, and, as in many societies, early Christians believed that those affected by leprosy were being punished by God for sinful behavior. Moral associations have persisted throughout history. Pope Gregory the Great (540-604) and Isidor of Seville (560-636) considered people with the disease to be heretics.[78]
Middle Ages[edit]
Medieval leper bell
It is believed that a rise in leprosy in Europe occurred in the Middle Ages based on the increased number of hospitals created to treat leprosy patients in the 12th and 13th centuries.[79][80][81] France alone had nearly 2,000 leprosariums during this period.
The social perception in medieval communities was generally one of fear, and those people infected with the disease were thought to be unclean, untrustworthy, and morally corrupt.[78] People with leprosy were also often required to wear clothing that identified them as such or carry a bell announcing their presence. Segregation from mainstream society was common. The third Lateran Council of 1179 and a 1346 edict by King Edward expelled lepers from city limits. Because of the moral stigma of the disease, methods of treatment were both physical and spiritual, and leprosariums were established under the purview of the church.[78][82]
19th century[edit]
Norway[edit]
Norway was the location of a progressive stance on leprosy tracking and treatment and played an influential role in European understanding of the disease. In 1832, Dr. JJ Hjort conducted the first leprosy survey, thus establishing a basis for epidemiological surveys. Subsequent surveys resulted in the establishment of a national leprosy registry to study the causes of leprosy and for tracking of the rate of infection.
Early leprosy research throughout Europe was conducted by Norwegian scientists Daniel Cornelius Danielssen and Carl Wilhelm Boeck. Their work resulted in the establishment of the National Leprosy Research and Treatment Center. Danielssen and Boeck believed the cause of leprosy transmission was hereditary. This stance was influential in advocating for the isolation of those infected by gender to prevent reproduction.[83][84][85]
Colonialism and imperialism[edit]
Father Damien on his deathbed in 1889
Though leprosy in Europe was again on the decline by the 1860s, Western countries embraced isolation treatment out of fear of the spread of disease from developing countries, minimal understanding of bacteriology, lack of diagnostic ability or knowledge of how contagious the disease was, and missionary activity.[75] Growing imperialism and pressures of the industrial revolution resulted in a Western presence in countries where leprosy was endemic, namely the British presence in India. Isolation treatment methods were observed by Surgeon-Mayor Henry Vandyke Carter of the British Colony in India while visiting Norway, and these methods were applied in India with the financial and logistical assistance of religious missionaries. Colonial and religious influence and associated stigma continued to be a major factor in the treatment and public perception of leprosy in endemic developing countries until the mid-twentieth century.[75]
Stigma[edit]
See also: Leprosy stigma
Despite effective treatment and education efforts, leprosy stigma continues to be problematic in developing countries where the disease is common. Leprosy is most common amongst impoverished or marginalized populations where social stigma is likely to be compounded by other social inequities. Fears of ostracism, loss of employment, or expulsion from family and society may contribute to a delayed diagnosis and treatment.
Folk beliefs, lack of education, and religious connotations of the disease continue to influence social perceptions of those afflicted in many parts of the world. In Brazil, for example, folklore holds that leprosy is transmitted by dogs, it is a disease associated with sexual promiscuity, and is sometimes thought to be punishment for sins or moral transgressions.[86] Socioeconomic factors also have a direct impact. Lower-class domestic workers who are often employed by those in a higher socioeconomic class may find their employment in jeopardy as physical manifestations of the disease become apparent. Skin discoloration and darker pigmentation resulting from the disease also have social repercussions.
In extreme cases in northern India, leprosy is equated with an "untouchable" status that "often persists long after (individuals with leprosy) have been cured of the disease, creating lifelong prospects of divorce, eviction, loss of employment, and ostracism from family and social networks." [87]
Programs and treatment[edit]
The WHO states that diagnosis and treatment with MDT are easy and effective, and a 45% decline in disease burden has occurred since MDT has become more widely available. The organization emphasizes the importance of fully integrating leprosy treatment into public health services, effective diagnosis and treatment, and access to information.[88]
In some instances in India, community-based rehabilitation is embraced by local governments and NGOs alike. Often, the identity cultivated by a community environment is preferable to reintegration, and models of self-management and collective agency independent of NGOs and government support have been desirable and successful.[89]
Notable cases[edit]
Saint Damien DeVeuster, a Roman Catholic priest from Belgium, himself eventually contracting leprosy, ministered to lepers who had been placed under a government-sanctioned medical quarantine on the island of Molokaʻi in the Kingdom of Hawaiʻi.[90]
Baldwin IV of Jerusalem was a Christian king of Latin Jerusalem afflicted with leprosy.[91]
King Henry IV of England (reigned 1399 to 1413) possibly had leprosy.[92]
Vietnamese poet Hàn Mặc Tử[93]
Ōtani Yoshitsugu, a Japanese daimyō[94]
Forough Farrokhzad made a 22-minute documentary about a leprosy colony in Iran in 1962 called The House Is Black. The film humanizes the people affected and opens by saying that "there is no shortage of ugliness in the world, but by closing our eyes on ugliness, we will intensify it."
Other animals[edit]
Wild nine-banded armadillos (Dayspus novemcinctus) in south central United States often carry Mycobacterium leprae.[95] This is believed to be because armadillos have such a low body temperature. Leprosy lesions appear mainly in cooler body regions such as the skin and mucous membranes of the upper respiratory tract. Because of armadillos' armor, skin lesions are hard to see.[96] Abrasions around the eyes, nose and feet are the most common signs. Infected armadillos make up a large reservoir of M. leprae and may be a source of infection for some humans in the United States or other locations in the armadillos' home range. In armadillo leprosy, lesions did not persist at the site of entry in animals, M. leprae multiplied in macrophages at the site of inoculation and lymph nodes.[97]
See also[edit]
Noma (disease)
References[edit]
Jump up ^ "Definition of leprosy". The Free Dictionary. Retrieved 2015-01-25.
^ Jump up to: a b c d e f g h i j k l m n o p q r s Suzuki K, Akama T, Kawashima A, Yoshihara A, Yotsu RR, Ishii N (February 2012). "Current status of leprosy: epidemiology, basic science and clinical perspectives". The Journal of dermatology. 39 (2): 121–9. doi:10.1111/j.1346-8138.2011.01370.x. PMID 21973237.
^ Jump up to: a b c d e f g h i j k l "Leprosy Fact sheet N°101". World Health Organization. January 2014. Archived from the original on 2013-12-12.
^ Jump up to: a b c d "New Leprosy Bacterium: Scientists Use Genetic Fingerprint To Nail 'Killing Organism'". ScienceDaily. 2008-11-28. Archived from the original on 2010-03-13. Retrieved 2010-01-31.
^ Jump up to: a b c Schreuder, P.A.M.; Noto, S.; Richardus J.H. (January 2016). "Epidemiologic trends of leprosy for the 21st century". Clinics in Dermatology. 34 (1): 24–31. doi:10.1016/j.clindermatol.2015.11.001. PMID 26773620.
Jump up ^ GBD 2015 Disease and Injury Incidence and Prevalence, Collaborators. (8 October 2016). "Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015". Lancet. 388 (10053): 1545–1602. doi:10.1016/S0140-6736(16)31678-6. PMC 5055577  . PMID 27733282.
^ Jump up to: a b "Hansen's Disease (Leprosy) Transmission". cdc.gov. April 29, 2013. Archived from the original on 13 March 2015. Retrieved 28 February 2015.
Jump up ^ "Global leprosy situation, 2012". Wkly. Epidemiol. Rec. 87 (34): 317–28. August 2012. PMID 22919737.
^ Jump up to: a b c d Rodrigues LC; Lockwood DNj (June 2011). "Leprosy now: epidemiology, progress, challenges, and research gaps". The Lancet Infectious Diseases. 11 (6): 464–70. doi:10.1016/S1473-3099(11)70006-8. PMID 21616456.
Jump up ^ "Hansen's Disease Data & Statistics". Health Resources and Services Administration. Archived from the original on 4 January 2015. Retrieved 12 January 2015.
Jump up ^ Walsh F (2007-03-31). "The hidden suffering of India's lepers". BBC News. Archived from the original on 2007-05-29.
Jump up ^ Lyn TE (2006-09-13). "Ignorance breeds leper colonies in China". Independat News & Media. Archived from the original on 2010-04-08. Retrieved 2010-01-31.
^ Jump up to: a b Byrne, Joseph P. (2008). Encyclopedia of pestilence, pandemics, and plagues. Westport, Conn.[u.a.]: Greenwood Press. p. 351. ISBN 978-0-313-34102-1.
Jump up ^ editors, Enrico Nunzi, Cesare Massone, (2012). Leprosy a practical guide. Milan: Springer. p. 326. ISBN 978-88-470-2376-5. Archived from the original on 2017-09-08.
Jump up ^ "Neglected Tropical Diseases". cdc.gov. June 6, 2011. Archived from the original on 4 December 2014. Retrieved 28 November 2014.
Jump up ^ McMenamin, Dorothy (2011). Leprosy and stigma in the South Pacific : a region-by-region history with first person accounts. Jefferson, N.C.: McFarland. p. 17. ISBN 978-0-7864-6323-7. Archived from the original on 2016-05-19.
^ Jump up to: a b Ryan, Kenneth J.; Ray, C. George, eds. (2004). Sherris Medical Microbiology (4th ed.). McGraw Hill. pp. 451–3. ISBN 0-8385-8529-9. OCLC 61405904.
^ Jump up to: a b "Lifting the stigma of leprosy: a new vaccine offers hope against an ancient disease". Time. 119 (19): 87. May 1982. PMID 10255067. Archived from the original on 2008-12-02.
^ Jump up to: a b Kulkarni GS (2008). Textbook of Orthopedics and Trauma (2 ed.). Jaypee Brothers Publishers. p. 779. ISBN 978-81-8448-242-3.
Jump up ^ "Q and A about leprosy". American Leprosy Missions. Archived from the original on 2012-10-04. Retrieved 2011-01-22. Do fingers and toes fall off when someone gets leprosy? No. The bacillus attacks nerve endings and destroys the body's ability to feel pain and injury. Without feeling pain, people injure themselves on fire, thorns, rocks, even hot coffee cups. Injuries become infected and result in tissue loss. Fingers and toes become shortened and deformed as the cartilage is absorbed into the body.
Jump up ^ McMurray DN (1996). "Mycobacteria and Nocardia". In Baron S; et al. Baron's Medical Microbiology (4th ed.). Univ of Texas Medical Branch. ISBN 0-9631172-1-1. OCLC 33838234. Archived from the original on 2009-02-12.
Jump up ^ Bhattacharya S, Vijayalakshmi N, Parija SC (1 October 2002). "Uncultivable bacteria: Implications and recent trends towards identification". Indian journal of medical microbiology. 20 (4): 174–7. PMID 17657065. Archived from the original on 27 September 2007.
Jump up ^ Meredith, Anna; Del Pozo, Jorge; Smith, Sionagh; Milne, Elspeth; Stevenson, Karen; McLuckie, Joyce (September 2014). "Leprosy in red squirrels in Scotland". Veterinary Record. 175 (11): 285–286. doi:10.1136/vr.g5680. PMID 25234460.
Jump up ^ Red squirrels in the British Isles are infected with leprosy bacilli, Dr. Andrej Benjak, Prof Anna Meredith and others, Science, 11 November 2016 Archived 11 November 2016 at the Wayback Machine..Retrieved 11 November 2016.
Jump up ^ Leprosy revealed in red squirrels across the British Isles, Damian Carrington, 11 November 2016 Archived 11 November 2016 at the Wayback Machine..Retrieved 11 November 2016.
Jump up ^ Lockwood DN, Lambert SM (January 2011). "Human immunodeficiency virus and leprosy: an update". Dermatologic clinics. 29 (1): 125–8. doi:10.1016/j.det.2010.08.016. PMID 21095536.
^ Jump up to: a b c d e f g "Leprosy". WHO. 2009-08-01. Archived from the original on 2010-02-09. Retrieved 2010-01-31.
Jump up ^ Brosch, Roland; Stinear, Timothy P. (11 November 2016). "Leprosy in red squirrels". Science. 354 (6313): 702–703. doi:10.1126/science.aal0145. Archived from the original on 8 September 2017. Retrieved 2016-11-11.
Jump up ^ Truman RW, Singh P, Sharma R, Busso P, Rougemont J, Paniz-Mondolfi A, Kapopoulou A, Brisse S, Scollard DM, Gillis TP, Cole ST (April 2011). "Probable Zoonotic Leprosy in the Southern United States". The New England Journal of Medicine. Massachusetts Medical Society. 364 (17): 1626–1633. doi:10.1056/NEJMoa1010536. PMC 3138484  . PMID 21524213. Archived from the original on 2011-11-02.
^ Jump up to: a b "What Is Leprosy?" THE MEDICAL NEWS | from News-Medical.Net – Latest Medical News and Research from Around the World. Web. 20 Nov. 2010. "Archived copy". Archived from the original on 2013-06-06. Retrieved 2013-05-14. .
Jump up ^ Rees RJ, McDougall AC; McDougall (1977). "Airborne infection with Mycobacterium leprae in mice". J Med Microbiol. 10 (1): 63–8. doi:10.1099/00222615-10-1-63. PMID 320339.
Jump up ^ Cook, Gordon C. (2009). Manson's tropical diseases (22nd ed.). [Edinburgh]: Saunders. p. 1056. ISBN 978-1-4160-4470-3. Archived from the original on 2017-09-04.
Jump up ^ Buschman E, Skamene E (Jun 2004). "Linkage of leprosy susceptibility to Parkinson's disease genes" (PDF). International journal of leprosy and other mycobacterial diseases. 72 (2): 169–70. doi:10.1489/1544-581X(2004)072<0169:LOLSTP>2.0.CO;2. ISSN 0148-916X. PMID 15301585. Archived (PDF) from the original on January 5, 2012. Retrieved January 31, 2011.
Jump up ^ Alcaïs A, Mira M, Casanova JL, Schurr E, Abel L (2005). "Genetic dissection of immunity in leprosy". Curr. Opin. Immunol. 17 (1): 44–8. doi:10.1016/j.coi.2004.11.006. PMID 15653309.
Jump up ^ "Diagnosis of Leprosy." WHO. from "Archived copy". Archived from the original on 2014-06-05. Retrieved 2014-07-14. accessed on 14 July 2014.
Jump up ^ U.S. Department of Health and Human Services, Health Resources and Services Administration. (n.d.). National Hansen's disease (leprosy) program Retrieved from "Archived copy". Archived from the original on 2011-02-10. Retrieved 2013-05-12.
Jump up ^ Smith DS (2008-08-19). "Leprosy: Overview". eMedicine Infectious Diseases. Archived from the original on 2010-02-18. Retrieved 2010-02-01.
Jump up ^ Singh N, Manucha V, Bhattacharya SN, Arora VK, Bhatia A; Manucha; Bhattacharya; Arora; Bhatia (June 2004). "Pitfalls in the cytological classification of borderline leprosy in the Ridley-Jopling scale". Diagn. Cytopathol. 30 (6): 386–8. doi:10.1002/dc.20012. PMID 15176024. CS1 maint: Multiple names: authors list (link)
Jump up ^ Ridley DS, Jopling WH; Jopling (1966). "Classification of leprosy according to immunity. A five-group system". Int. J. Lepr. Other Mycobact. Dis. 34 (3): 255–73. PMID 5950347.
Jump up ^ Modlin RL (June 1994). "Th1-Th2 paradigm: insights from leprosy". J. Invest. Dermatol. 102 (6): 828–32. doi:10.1111/1523-1747.ep12381958. PMID 8006444.
Jump up ^ James, William D.; Berger, Timothy G.; et al. (2006). Andrews' Diseases of the Skin: clinical Dermatology. Saunders Elsevier. ISBN 0-7216-2921-0.
Jump up ^ Jardim MR, Antunes SL, Santos AR, Nascimento OJ, Nery JA, Sales AM, Illarramendi X, Duppre N, Chimelli L, Sampaio EP, Sarno EP; Antunes; Santos; et al. (July 2003). "Criteria for diagnosis of pure neural leprosy". J. Neurol. 250 (7): 806–9. doi:10.1007/s00415-003-1081-5. PMID 12883921. CS1 maint: Multiple names: authors list (link)
Jump up ^ Mendiratta V, Khan A, Jain A; Khan; Jain (2006). "Primary neuritic leprosy: a reappraisal at a tertiary care hospital". Indian J Lepr. 78 (3): 261–7. PMID 17120509. CS1 maint: Multiple names: authors list (link)
Jump up ^ Ishida Y, Pecorini L, Guglielmelli E; Pecorini l; Guglielmelli e (July 2000). "Three cases of pure neuritic (PN) leprosy at detection in which skin lesions became visible during their course". Nihon Hansenbyo Gakkai Zasshi. 69 (2): 101–6. doi:10.5025/hansen.69.101. PMID 10979277. CS1 maint: Multiple names: authors list (link)
Jump up ^ Mishra B, Mukherjee A, Girdhar A, Husain S, Malaviya GN, Girdhar BK; Mukherjee; Girdhar; Husain; Malaviya; Girdhar (1995). "Neuritic leprosy: further progression and significance". Acta Leprol. 9 (4): 187–94. PMID 8711979. CS1 maint: Multiple names: authors list (link)
Jump up ^ Talwar S, Jha PK, Tiwari VD; Jha; Tiwari (September 1992). "Neuritic leprosy: epidemiology and therapeutic responsiveness". Lepr Rev. 63 (3): 263–8. PMID 1406021. CS1 maint: Multiple names: authors list (link)
^ Jump up to: a b c Rodrigues LC, Lockwood DNj; Lockwood (June 2011). "Leprosy now: epidemiology, progress, challenges, and research gaps". Lancet Infect Dis. 11 (6): 464–70. doi:10.1016/S1473-3099(11)70006-8. PMID 21616456.
Jump up ^ Duthie MS, Gillis TP, Reed SG; Gillis; Reed (November 2011). "Advances and hurdles on the way toward a leprosy vaccine". Hum Vaccin. 7 (11): 1172–83. doi:10.4161/hv.7.11.16848. PMC 3323495  . PMID 22048122. CS1 maint: Multiple names: authors list (link)
Jump up ^ Setia MS, Steinmaus C, Ho CS, Rutherford GW; Steinmaus; Ho; Rutherford (March 2006). "The role of BCG in prevention of leprosy: a meta-analysis". Lancet Infect Dis. 6 (3): 162–70. doi:10.1016/S1473-3099(06)70412-1. PMID 16500597. CS1 maint: Multiple names: authors list (link)
Jump up ^ Merle CS, Cunha SS, Rodrigues LC; Cunha; Rodrigues (2010). "BCG vaccination and leprosy protection: Review of current evidence and status of BCG in leprosy control". Expert Review of Vaccines. 9 (2): 209–222. doi:10.1586/ERV.09.161. PMID 20109030. CS1 maint: Multiple names: authors list (link)
Jump up ^ "Leprosy Vaccine". American Leprosy Missions. Archived from the original on November 15, 2015. Retrieved October 20, 2015.
Jump up ^ "Trial set for world's first leprosy vaccine". The Guardian. June 6, 2014. Archived from the original on October 11, 2015. Retrieved October 20, 2015.
Jump up ^ "China's Mars plans, leprosy vaccine and self-driving taxis". Nature. 2016-08-31. Archived from the original on 2016-09-02. Retrieved 2016-09-03.
Jump up ^ "Mortality and Burden of Disease Estimates for WHO Member States in 2002" (xls). World Health Organization. 2002. Archived from the original on 2013-01-16.
Jump up ^ "Archived copy". Archived from the original on 2013-12-12. Retrieved 2014-01-01.
^ Jump up to: a b "Global Leprosy Update, 2013: Reducing Disease Burden" (PDF). Weekly Epidemiological Record. World Health Organization. 36 (89): 389–400. 5 September 2014. Archived (PDF) from the original on 3 February 2016. Retrieved 26 February 2016.
Jump up ^ "About ILEP". ILEP. Archived from the original on 2014-08-12. Retrieved 2014-08-25.
Jump up ^ WHO (1995). "Leprosy disabilities: magnitude of the problem". Weekly Epidemiological Record. 70 (38): 269–75. PMID 7577430.
Jump up ^ World Health Organization. (1985). "Epidemiology of leprosy in relation to control. Report of a WHO Study Group". World Health Organ Tech Rep Ser. Geneva: World Health Organization. 716: 1–60. ISBN 92-4-120716-7. OCLC 12095109. PMID 3925646.
Jump up ^ Monot, Marc; Honoré, Nadine; Garnier, Thierry; Araoz, Romul; Coppée, Jean-Yves; Lacroix, Céline; Sow, Samba; Spencer, John S.; Truman, Richard W.; Williams, Diana L.; Gelber, Robert; Virmond, Marcos; Flageul, Béatrice; Cho, Sang-Nae; Ji, Baohong; Paniz-Mondolfi, Alberto; Convit, Jacinto; Young, Saroj; Fine, Paul E.; Rasolofo, Voahangy; Brennan, Patrick J.; Cole, Stewart T. (13 May 2005). "On the Origin of Leprosy". Science. 308 (5724): 1040–1042. doi:10.1126/science/1109759. PMID 15894530.
Jump up ^ Robbins, G; Mushrif, V.; Misra, V.N.; Mohanty, R.K.; Shinde, V.S.; Gray, K.M.; Schug, M.D. (May 2009). "Ancient skeletal evidence for Leprosy in India (2000 B.C.)". PLoS ONE. 4 (5): e5669. doi:10.1371/journal.pone.0005669. PMC 2682583  . PMID 19479078.
Jump up ^ Robbins Schug, G; Blevins, K. Elaine; Cox, Brett; Gray, Kelsey; Mushrif-Tripathy, Veena (December 2013). "Infection, Disease, and Biosocial Process at the End of the Indus Civilization". PLoS ONE. 0084814 (12): e84814. doi:10.1371/journal.pone.0084814.
Jump up ^ Francis Adams, The Seven Books of Paulus Aegineta: Translated from the Greek with Commentary Embracing a Complete View of the Knowledge Possessed by the Greeks, Romans and Arabians on all Subjects Connected with Medicine and Surgery, 3 vols. (London: Sydenham Society, 1678
Jump up ^ Roman: Celsus, Pliny, Serenus Samonicus, Scribonius Largus, Caelius Aurelianus, Themison, Octavius Horatianus, Marcellus the Emperic; Greek: Aretaeus, Plutarch, Galen, Oribasius, Aetius, Actuarius, Nonnus, Psellus, Leo, Myrepsus; Arabic: Scrapion, Avenzoar, Albucasis, the Haly Abbas translated by Stephanus Antiochensis, Alsharavius, Rhases, and Guido de Cauliaco
Jump up ^ Robbins, Gwen; Tripathy, V. Mushrif; Misra, V. N.; Mohanty, R. K.; Shinde, V. S.; Gray, Kelsey M.; Schug, Malcolm D. (May 27, 2009). "Ancient Skeletal Evidence for Leprosy in India (2000 B.C.)". PLoS ONE. 4 (5): e5669. doi:10.1371/journal.pone.0005669. PMC 2682583  . PMID 19479078.
Jump up ^ "DNA of Jesus-Era Shrouded Man in Jerusalem Reveals Earliest Case of Leprosy". ScienceDaily. 2009-12-16. Archived from the original on 2009-12-20. Retrieved 2010-01-31.
Jump up ^ Irgens LM (2002). "The discovery of the leprosy bacillus". Tidsskr nor Laegeforen. 122 (7): 708–9. PMID 11998735.
Jump up ^ Andrew Baum; et al. (1997). Cambridge handbook of psychology, health and medicine. Cambridge, Angleterre: Cambridge University Press. p. 521. ISBN 978-0-521-43686-1. Archived from the original on 2016-06-11.
Jump up ^ Rees RJ, Pearson JM, Waters MF; Pearson; Waters (1970). "Experimental and Clinical Studies on Rifampicin in Treatment of Leprosy". Br Med J. 688 (1): 89–92. doi:10.1136/bmj.1.5688.89. PMC 1699176  . PMID 4903972. CS1 maint: Multiple names: authors list (link)
Jump up ^ Yawalkar SJ, McDougall AC, Languillon J, Ghosh S, Hajra SK, Opromolla DV, Tonello CJ; McDougall; Languillon; Ghosh; Hajra; Opromolla; Tonello (1982). "Once-monthly rifampicin plus daily dapsone in initial treatment of lepromatous leprosy". Lancet. 319 (8283): 1199–1202. doi:10.1016/S0140-6736(82)92334-0. PMID 6122970. CS1 maint: Multiple names: authors list (link)
Jump up ^ Syphilis through history Archived 2013-05-13 at the Wayback Machine. Encyclopædia Britannica
Jump up ^ "Communicable Diseases Department, Leprosy FAQ". World Health Organization. 2006-05-25. Archived from the original on 2010-02-01. Retrieved 2010-01-31.
Jump up ^ Japan repealed its "Leprosy Prevention Laws" in 1996, but former patients still reside in sanatoriums. "Koizumi apologises for leper colonies". BBC News. May 25, 2001. Archived from the original on April 17, 2009. and Former Hansen's disease patients still struggling with prejudice Japan Times June 7, 2007 Archived August 26, 2009, at the Wayback Machine..
Jump up ^ Arch Dermato Syphilis 1898; 44:159–174
^ Jump up to: a b c Gussow, Zachary (1989). Leprosy, Racism, and Public Health. Boulder, Colorado: Westview Press. ISBN 978-0-8133-0674-2.
Jump up ^ Jacob, Jesse; Franco-Paredes, Carlos (2008). "The stigmatization of leprosy in India and its impact on future approaches to elimination and control". PLoS Neglected Tropical Diseases. 2: e113. doi:10.1371/journal.pntd.0000113. Archived from the original on 2017-02-20.
Jump up ^ [See: Orr, James, M.A., D.D. General Editor. "Entry for 'LEPER; LEPROSY'". "International Standard Bible Encyclopedia". 1915. Access-date=January 6, 2017
^ Jump up to: a b c Covey, Herbert C. (2001). "People with leprosy (Hansen's disease) during the Middle Ages" (PDF). Social Science Journal. 38 (2): 315–321. doi:10.1016/S0362-3319(01)00116-1. Archived from the original (PDF) on August 15, 2016. Retrieved June 25, 2016.
Jump up ^ Le Goff, Jacques (1990). The Medieval world. London: Collins & Brown. ISBN 1-85585-081-8.
Jump up ^ Clay, Rotha (1909). The Mediaeval Hospitals of England. Cornell University Library. ISBN 1-112-20443-1.
Jump up ^ Rubin, Stanley (1974). Medieval English medicine. New York: Barnes & Noble Books: Newton Abbot: David & Charles. ISBN 0-06-496016-1.
Jump up ^ Moore, R. I. (2007). The Formation of a Persecuting Society. Oxford: Blackwell. ISBN 1-4051-2964-6.
Jump up ^ Alter, Andrea (2010). Genetic susceptibility to leprosy. McGill University (Canada): ProQuest Dissertations Publishing. ISBN 978-0-494-72613-6.
Jump up ^ Svein Atle Skålevåg. "Daniel Cornelius Danielssen". Store norske leksikon. Archived from the original on January 13, 2017. Retrieved January 1, 2017.
Jump up ^ Svein Atle Skålevåg. "Carl Wilhelm Boeck". Store norske leksikon. Archived from the original on January 13, 2017. Retrieved January 1, 2017.
Jump up ^ White, Cassandra (2005). "Explaining a Complex Disease Process: Talking to Patients about Hansen's Disease (Leprosy) in Brazil". Medical Anthropology Quarterly. 19: 310–330. doi:10.1525/maq.2005.19.3.310. ISSN 0745-5194. JSTOR 3655365.
Jump up ^ Barret, Ronald (June 2005). "Self-Mortification and the Stigma of Leprosy in Northern India". Medical Anthropology Quarterly. 19: 216–230. doi:10.1525/maq.2005.19.2.216. ISSN 1548-1387. JSTOR 3655487.
Jump up ^ "World Health Organization". Archived from the original on 2014-03-14.
Jump up ^ Staples, James (2014). "Communities of the afflicted: constituting leprosy through place in South India". Medical Anthropology: Cross-Cultural Studies in Health and Illness. 33: 6–20. doi:10.1080/01459740.2012.714021. [permanent dead link]
Jump up ^ Tayman, John (2007). The Colony: The Harrowing True Story of the Exiles of Molokai. New York: Simon and Schuster. ISBN 978-0-7432-3301-9. Archived from the original on 2016-01-02.
Jump up ^ Hamilton, Bernard (2000). The leper king and his heirs: Baldwin IV and the Crusader Kingdom of Jerusalem. Cambridge, UK: Cambridge University Press. ISBN 0-521-64187-X.
Jump up ^ Webber, Roger (2015). Disease Selection: The Way Disease Changed the World. CABI. p. 8. ISBN 978-1-78064-682-4. Archived from the original on 2017-09-08.
Jump up ^ Cung giu Nguyên (1955). "Contemporary Vietnamese Writing". Books Abroad. University of Oklahoma. 29 (1): 19–25. doi:10.2307/40093803. JSTOR 40093803.
Jump up ^ Bryant A (1995). Sekigahara 1600: The Final Struggle for Power (Campaign Series, 40). Osprey Publishing (UK). ISBN 1-85532-395-8. Retrieved 2010-02-28.
Jump up ^ Truman, Richard (2005). "Leprosy in wild armadillos". Lepr Rev. 76: 198–208.
Jump up ^ Sharma, Rahul; Lahiri, Ramanuj; Scollard, David M.; Pena, Maria; Williams, Diana L.; Adams, Linda B.; Figarola, John; Truman, Richard W. (2013-01-01). "The armadillo: a model for the neuropathy of leprosy and potentially other neurodegenerative diseases". Disease Models & Mechanisms. 6 (1): 19–24. doi:10.1242/dmm.010215. ISSN 1754-8403. PMC 3529335  . PMID 23223615. Archived from the original on 2016-11-13.
Jump up ^ Job, C. K.; Drain, V.; Truman, R.; Deming, A. T.; Sanchez, R. M.; Hastings, R. C. (2016-06-01). "The pathogenesis of leprosy in the nine-banded armadillo and the significance of IgM antibodies to PGL-1". Indian Journal of Leprosy. 64 (2): 137–151. ISSN 0254-9395. PMID 1607712.
External links[edit]
Classification
V · T · D
ICD-10: A30
ICD-9-CM: 030
OMIM: 246300
MeSH: D007918
DiseasesDB: 8478
External resources
MedlinePlus: 001347
eMedicine: med/1281 derm/223 neuro/187
Patient UK: Leprosy

Wikimedia Commons has media related to Leprosy.
Leprosy at Curlie (based on DMOZ)
Links and resources Links to information about leprosy selected by the World Health Organization
[show]
v
t
e
Diseases of the skin and appendages by morphology
Growths
Epidermal
wart
callus
seborrheic keratosis
acrochordon
molluscum contagiosum
actinic keratosis
squamous-cell carcinoma
basal-cell carcinoma
Merkel-cell carcinoma
nevus sebaceous
trichoepithelioma
Pigmented
Freckles
lentigo
melasma
nevus
melanoma
Dermal and
subcutaneous
epidermal inclusion cyst
hemangioma
dermatofibroma (benign fibrous histiocytoma)
keloid
lipoma
neurofibroma
xanthoma
Kaposi's sarcoma
infantile digital fibromatosis
granular cell tumor
leiomyoma
lymphangioma circumscriptum
myxoid cyst
Rashes
With
epidermal
involvement
Eczematous
contact dermatitis
atopic dermatitis
seborrheic dermatitis
stasis dermatitis
lichen simplex chronicus
Darier's disease
glucagonoma syndrome
langerhans cell histiocytosis
lichen sclerosus
pemphigus foliaceus
Wiskott–Aldrich syndrome
Zinc deficiency
Scaling
psoriasis
tinea (corporis
cruris
pedis
manuum
faciei)
pityriasis rosea
secondary syphilis
mycosis fungoides
systemic lupus erythematosus
pityriasis rubra pilaris
parapsoriasis
ichthyosis
Blistering
herpes simplex
herpes zoster
varicella
bullous impetigo
acute contact dermatitis
pemphigus vulgaris
bullous pemphigoid
dermatitis herpetiformis
porphyria cutanea tarda
epidermolysis bullosa simplex
Papular
scabies
insect bite reactions
lichen planus
miliaria
keratosis pilaris
lichen spinulosus
transient acantholytic dermatosis
lichen nitidus
pityriasis lichenoides et varioliformis acuta
Pustular
acne vulgaris
acne rosacea
folliculitis
impetigo
candidiasis
gonococcemia
dermatophyte
coccidioidomycosis
subcorneal pustular dermatosis
Hypopigmented
tinea versicolor
vitiligo
pityriasis alba
postinflammatory hyperpigmentation
tuberous sclerosis
idiopathic guttate hypomelanosis
leprosy
hypopigmented mycosis fungoides
Without
epidermal
involvement
Red
Blanchable
Erythema
Generalized
drug eruptions
viral exanthems
toxic erythema
systemic lupus erythematosus
Localized
cellulitis
abscess
boil
erythema nodosum
carcinoid syndrome
fixed drug eruption
Specialized
urticaria
erythema (multiforme
migrans
gyratum repens
annulare centrifugum
ab igne)
Nonblanchable
Purpura
Macular
thrombocytopenic purpura
actinic/solar purpura
Papular
disseminated intravascular coagulation
vasculitis
Indurated
scleroderma/morphea
granuloma annulare
lichen sclerosis et atrophicus
necrobiosis lipoidica
Miscellaneous
disorders
Ulcers
Hair
telogen effluvium
androgenic alopecia
alopecia areata
systemic lupus erythematosus
tinea capitis
loose anagen syndrome
lichen planopilaris
folliculitis decalvans
acne keloidalis nuchae
Nail
onychomycosis
psoriasis
paronychia
ingrown nail
Mucous
membrane
Aphthous stomatitis
oral candidiasis
lichen planus
leukoplakia
pemphigus vulgaris
mucous membrane pemphigoid
cicatricial pemphigoid
herpesvirus
coxsackievirus
syphilis
systemic histoplasmosis
squamous-cell carcinoma
[show]
v
t
e
Gram-positive bacterial infection: Actinobacteria (primarily A00–A79, 001–041, 080–109)
Actinomycineae
Actinomycetaceae
Actinomyces israelii
Actinomycosis
Cutaneous actinomycosis
Tropheryma whipplei
Whipple's disease
Arcanobacterium haemolyticum
Arcanobacterium haemolyticum infection
Actinomyces gerencseriae
Propionibacteriaceae
Propionibacterium acnes
Corynebacterineae
Mycobacteriaceae
M. tuberculosis/
M. bovis
Tuberculosis: Ghon focus/Ghon's complex
Pott disease
brain
Meningitis
Rich focus
Tuberculous lymphadenitis
Tuberculous cervical lymphadenitis
cutaneous
Scrofuloderma
Erythema induratum
Lupus vulgaris
Prosector's wart
Tuberculosis cutis orificialis
Tuberculous cellulitis
Tuberculous gumma
Lichen scrofulosorum
Tuberculid
Papulonecrotic tuberculid
Primary inoculation tuberculosis
Miliary
Tuberculous pericarditis
Urogenital tuberculosis
Multi-drug-resistant tuberculosis
Extensively drug-resistant tuberculosis
M. leprae
Leprosy: Tuberculoid leprosy
Borderline tuberculoid leprosy
Borderline leprosy
Borderline lepromatous leprosy
Lepromatous leprosy
Histoid leprosy
Nontuberculous
R1:
M. kansasii
M. marinum
Aquarium granuloma
R2:
M. gordonae
R3:
M. avium complex/Mycobacterium avium/Mycobacterium intracellulare/MAP
MAI infection
M. ulcerans
Buruli ulcer
M. haemophilum
R4/RG:
M. fortuitum
M. chelonae
M. abscessus
Nocardiaceae
Nocardia asteroides/Nocardia brasiliensis
Nocardiosis
Rhodococcus equi
Corynebacteriaceae
Corynebacterium diphtheriae
Diphtheria
Corynebacterium minutissimum
Erythrasma
Corynebacterium jeikeium
Group JK corynebacterium sepsis
Bifidobacteriaceae
Gardnerella vaginalis
Authority control
GND: 4035392-8
HDS: 7983
NDL: 00569249
Retrieved from "https://en.wikipedia.org/w/index.php?title=Leprosy&oldid=837169859"
Categories:
Bacterial diseases
Leprosy
Hidden categories:
Webarchive template wayback links
CS1 maint: Multiple names: authors list
All articles with dead external links
Articles with dead external links from April 2018
Articles with permanently dead external links
Infobox medical condition (new)
Pages using div col without cols and colwidth parameters
Articles with Curlie links
Wikipedia articles with GND identifiers
RTT
RTTID
Navigation menu
Personal tools
Not logged in
Talk
Contributions
Create account
Log in
Namespaces
Article
Talk
Variants
Views
Read
Edit
View history
More
Search
Navigation
Main page
Contents
Featured content
Current events
Random article
Donate to Wikipedia
Wikipedia store
Interaction
Help
About Wikipedia
Community portal
Recent changes
Contact page
Tools
What links here
Related changes
Upload file
Special pages
Permanent link
Page information
Wikidata item
Cite this page
Print/export
Create a book
Download as PDF
Printable version
In other projects
Wikimedia Commons
Languages
Afrikaans
Akan
العربية
অসমীয়া
Asturianu
Azərbaycanca
تۆرکجه
বাংলা
Bân-lâm-gú
Беларуская
Беларуская (тарашкевіца)
Български
བོད་ཡིག
Bosanski
Brezhoneg
Català
Čeština
Chi-Chewa
ChiShona
Cymraeg
Dansk
Deutsch
ދިވެހިބަސް
Eesti
Ελληνικά
Español
Esperanto
Euskara
فارسی
Français
Gaeilge
Galego
ગુજરાતી
한국어
Հայերեն
हिन्दी
Hrvatski
Ido
Igbo
Bahasa Indonesia
IsiXhosa
Íslenska
Italiano
עברית
ಕನ್ನಡ
ქართული
Kaszëbsczi
Қазақша
Kiswahili
Kurdî
Кыргызча
Latina
Latviešu
Lietuvių
Lingála
Magyar
Македонски
മലയാളം
मराठी
Bahasa Melayu
Baso Minangkabau
Mìng-dĕ̤ng-ngṳ̄
Монгол
မြန်မာဘာသာ
Nederlands
नेपाली
日本語
Norsk
Norsk nynorsk
Occitan
ଓଡ଼ିଆ
Oromoo
Oʻzbekcha/ўзбекча
ਪੰਜਾਬੀ
پښتو
Polski
Português
Română
Runa Simi
Русский
Саха тыла
संस्कृतम्
Scots
Sesotho
Sesotho sa Leboa
Sicilianu
සිංහල
Simple English
سنڌي
SiSwati
Slovenčina
Slovenščina
Српски / srpski
Srpskohrvatski / српскохрватски
Basa Sunda
Suomi
Svenska
Tagalog
தமிழ்
తెలుగు
ไทย
Türkçe
Українська
اردو
Tiếng Việt
Võro
Winaray
Xitsonga
Yorùbá
粵語
中文
डोटेली
Kabɩyɛ
104 more
Edit links
This page was last edited on 19 April 2018, at 04:24.
Text is available under the Creative Commons Attribution-ShareAlike License; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.
Privacy policy
About Wikipedia
Disclaimers
Contact Wikipedia
Developers
Cookie statement
Mobile view
Enable previews

values: mw-page-base noprint

values: mw-head-base noprint

values: firstHeading firstHeading en

values: siteSub noprint

values: jump-to-nav mw-jump

attrs: href class title

values:
/wiki/Leprosy_(disambiguation)
mw-disambig
Leprosy (disambiguation)

attrs: role class

values:
note
hatnote navigation-not-searchable

values: /wiki/Ieper mw-redirect Ieper

values:
/wiki/Infectious_disease
mw-redirect
Infectious disease

values:
/wiki/Chronic_(medicine)
mw-redirect
Chronic (medicine)

values:
/wiki/Neglected_tropical_disease
mw-redirect
Neglected tropical disease

values:
/wiki/Upper_respiratory_tract
mw-redirect
Upper respiratory tract

values: Edit section: M. leprae and M. lepromatosis

attrs: alt src width height class srcset data-file-width data-file-height

values:
/wiki/Ziehl-Neelsen_stain
mw-redirect
Ziehl-Neelsen stain

values:
nofollow
external text
https://omim.org/entry/609888

values:
nofollow
external text
https://omim.org/entry/607572

values:
nofollow
external text
https://omim.org/entry/246300

values:
nofollow
external text
https://omim.org/entry/610988

values:
nofollow
external text
https://omim.org/entry/613223

values:
nofollow
external text
https://omim.org/entry/613407

values: float: right; margin-left:15px; text-align:center

values:
/wiki/Plaque_(dermatology)
mw-redirect
Plaque (dermatology)

values:
/wiki/Bacillus_Calmette-Gu%C3%A9rin
mw-redirect
Bacillus Calmette-Guérin

values:
/wiki/Antibiotic_resistance
mw-redirect
Antibiotic resistance

values: display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #b3b3b3; color:black; font-size:100%; text-align:center;

values: -webkit-column-break-inside: avoid;page-break-inside: avoid;break-inside: avoid-column

values: display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ffff65; color:black; font-size:100%; text-align:center;

values: display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #fff200; color:black; font-size:100%; text-align:center;

values: display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ffdc00; color:black; font-size:100%; text-align:center;

values: display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ffc600; color:black; font-size:100%; text-align:center;

values: display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ffb000; color:black; font-size:100%; text-align:center;

values: display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ff9a00; color:black; font-size:100%; text-align:center;

values: display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ff8400; color:black; font-size:100%; text-align:center;

values: display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ff6e00; color:black; font-size:100%; text-align:center;

values: display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ff5800; color:black; font-size:100%; text-align:center;

values: display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ff4200; color:black; font-size:100%; text-align:center;

values: display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #ff2c00; color:black; font-size:100%; text-align:center;

values: display:inline-block; width:1.5em; height:1.5em; margin:1px 0; border:1px solid black; background-color: #cb0000; color:black; font-size:100%; text-align:center;

values: div-col columns column-count column-count-2

values: -moz-column-count: 2; -webkit-column-count: 2; column-count: 2;

values: National Hansen's Disease Museum (Japan)

values:
/wiki/British_India
mw-redirect
British India

values:
/wiki/Atharava_Veda
mw-redirect
Atharava Veda

values:
/wiki/Laws_of_Manu
mw-redirect
Laws of Manu

values:
/wiki/Ritual_impurity
mw-redirect
Ritual impurity

values:
/wiki/Early_Christians
mw-redirect
Early Christians

values:
/wiki/Gregory_the_Great
mw-redirect
Gregory the Great

values:
/wiki/Isidor_of_Seville
mw-redirect
Isidor of Seville

values:
/wiki/Third_Lateran_Council
mw-redirect
Third Lateran Council

values: Edit section: Colonialism and imperialism

values:
/wiki/Nine-banded_armadillos
mw-redirect
Nine-banded armadillos

values:
/wiki/PubMed_Identifier
mw-redirect
PubMed Identifier

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/21973237

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/26773620

attrs: alt src title width height srcset data-file-width data-file-height

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/27733282

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/22919737

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/21616456

values:
nofollow
external text
//www.worldcat.org/oclc/61405904

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/10255067

values:
nofollow
external text
http://www.leprosy.org/leprosy-faqs

values:
nofollow
external text
//www.worldcat.org/oclc/33838234

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/17657065

values:
nofollow
external text
//doi.org/10.1136%2Fvr.g5680

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/25234460

values:
nofollow
external text
//doi.org/10.1016%2Fj.det.2010.08.016

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/21095536

values:
nofollow
external text
//doi.org/10.1126%2Fscience.aal0145

values:
nofollow
external text
//doi.org/10.1056%2FNEJMoa1010536

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/21524213

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/320339

values:
nofollow
external text
//www.worldcat.org/issn/0148-916X

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/15301585

values:
nofollow
external text
//doi.org/10.1016%2Fj.coi.2004.11.006

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/15653309

values:
nofollow
http://www.who.int/lep/diagnosis/en/
external text

values:
nofollow
http://www.hrsa.gov/hansens/
external text

values:
nofollow
external text
//doi.org/10.1002%2Fdc.20012

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/15176024

values: Category:CS1 maint: Multiple names: authors list

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/5950347

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/8006444

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/12883921

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/17120509

values:
nofollow
external text
//doi.org/10.5025%2Fhansen.69.101

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/10979277

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/8711979

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/1406021

values:
nofollow
external text
//doi.org/10.4161%2Fhv.7.11.16848

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/22048122

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/16500597

values:
nofollow
external text
//doi.org/10.1586%2FERV.09.161

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/20109030

values:
nofollow
http://www.leprosy.org/leprosy-vaccine/
external text

values:
nofollow
http://www.ilep.org.uk/about-ilep/
external text

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/7577430

values:
nofollow
external text
//www.worldcat.org/oclc/12095109

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/3925646

values:
nofollow
external text
//doi.org/10.1126%2Fscience%2F1109759

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/15894530

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/19479078

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/11998735

values:
nofollow
external text
//doi.org/10.1136%2Fbmj.1.5688.89

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/4903972

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/6122970

values:
/wiki/PLoS_Neglected_Tropical_Diseases
mw-redirect
PLoS Neglected Tropical Diseases

values:
/wiki/Social_Science_Journal
mw-redirect
Social Science Journal

values:
/wiki/David_%26_Charles
mw-redirect
David & Charles

values:
nofollow
external text
https://snl.no/Carl_Wilhelm_Boeck

values:
nofollow
external text
//doi.org/10.1525%2Fmaq.2005.19.3.310

values:
nofollow
external text
//www.worldcat.org/issn/0745-5194

values:
nofollow
external text
//www.jstor.org/stable/3655365

values:
nofollow
external text
//doi.org/10.1525%2Fmaq.2005.19.2.216

values:
nofollow
external text
//www.worldcat.org/issn/1548-1387

values:
nofollow
external text
//www.jstor.org/stable/3655487

values:
nofollow
http://www.who.int/lep/en/
external text

values:
nofollow
external text
//doi.org/10.2307%2F40093803

values:
nofollow
external text
//www.jstor.org/stable/40093803

values:
nofollow
external text
//doi.org/10.1242%2Fdmm.010215

values:
nofollow
external text
//www.worldcat.org/issn/1754-8403

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/23223615

values:
nofollow
external text
//www.worldcat.org/issn/0254-9395

values:
nofollow
external text
//www.ncbi.nlm.nih.gov/pubmed/1607712

values: International Statistical Classification of Diseases and Related Health Problems

values:
nofollow
external text
https://patient.info/doctor/leprosy-pro

values: width:22em;width:100%; margin:0 0 0.5em 0;

values:
nofollow
http://www.who.int/lep/resources/en/
external text

values: Template:Diseases of the skin and appendages by morphology

values: Template talk:Diseases of the skin and appendages by morphology

values:
/wiki/Squamous-cell_carcinoma
mw-redirect
Squamous-cell carcinoma

values:
/wiki/Glucagonoma_syndrome
mw-redirect
Glucagonoma syndrome

values:
/wiki/Scale_(dermatology)
mw-redirect
Scale (dermatology)

values:
/wiki/Herpes_zoster
mw-redirect
Herpes zoster

values: Pityriasis lichenoides et varioliformis acuta

values:
/wiki/Acne_vulgaris
mw-redirect
Acne vulgaris

values:
/wiki/Acne_rosacea
mw-redirect
Acne rosacea

values:
/wiki/Subcorneal_pustular_dermatosis
mw-redirect
Subcorneal pustular dermatosis

values:
/wiki/Fixed_drug_eruption
mw-redirect
Fixed drug eruption

values:
/wiki/Androgenic_alopecia
mw-redirect
Androgenic alopecia

values:
/wiki/Lichen_planopilaris
mw-redirect
Lichen planopilaris

values:
/wiki/Mucous_membrane_pemphigoid
mw-redirect
Mucous membrane pemphigoid

values: nowraplinks collapsible collapsed navbox-inner

values: Template talk:Gram-positive actinobacteria diseases

values:
/wiki/Gram-positive_bacterial_infection
mw-redirect
Gram-positive bacterial infection

values: ICD-10 Chapter I: Certain infectious and parasitic diseases

values: List of ICD-9 codes 001–139: infectious and parasitic diseases

values:
/wiki/Cutaneous_tuberculosis
mw-redirect
Cutaneous tuberculosis

values:
row
navbox-group
width:1%;background: transparent;

values:
/wiki/Mycobacterium_avium
mw-redirect
Mycobacterium avium

values:
/wiki/Mycobacterium_intracellulare
mw-redirect
Mycobacterium intracellulare

values: Mycobacterium avium subspecies paratuberculosis

values: nowraplinks hlist collapsible autocollapse navbox-inner

values:
nofollow
external text
https://d-nb.info/gnd/4035392-8

values: Category:Webarchive template wayback links

values: Category:All articles with dead external links

values: Category:Articles with dead external links from April 2018

values: Category:Articles with permanently dead external links

values: Category:Infobox medical condition (new)

values: Category:Pages using div col without cols and colwidth parameters

values: Category:Wikipedia articles with GND identifiers

values: Discussion about edits from this IP address [ctrl-alt-n]

values:
/wiki/Leprosy
View the content page [ctrl-alt-c]
c

values:
/w/index.php?title=Leprosy&action=edit
Edit this page [ctrl-alt-e]
e

values: Find background information on current events

values:
/wiki/Special:Random
Load a random article [ctrl-alt-x]
x

values: portal navigation p-navigation p-navigation-label

values: Guidance on how to use and edit Wikipedia

values: About the project, what you can do, where to find things

values: A list of recent changes in the wiki [ctrl-alt-r]

values: portal navigation p-interaction p-interaction-label

values: List of all English Wikipedia pages containing links to this page [ctrl-alt-j]

values: Recent changes in pages linked from this page [ctrl-alt-k]

values:
/wiki/Wikipedia:File_Upload_Wizard
Upload files [ctrl-alt-u]
u

values: A list of all special pages [ctrl-alt-q]

values: Permanent link to this revision of the page

values: Link to connected data repository item [ctrl-alt-g]

values: Printable version of this page [ctrl-alt-p]

values: portal navigation p-wikibase-otherprojects p-wikibase-otherprojects-label

values:
interlanguage-link interwiki-af
display: none;

values:
https://ak.wikipedia.org/wiki/Kwata
Kwata – Akan
ak
ak
interlanguage-link-target

values:
interlanguage-link interwiki-ak
display: none;

values: interlanguage-link interwiki-ar badge-Q17437796 badge-featuredarticle

values:
interlanguage-link interwiki-as
display: none;

values:
https://ast.wikipedia.org/wiki/Llepra
Llepra – Asturian
ast
ast
interlanguage-link-target

values:
interlanguage-link interwiki-ast
display: none;

values:
interlanguage-link interwiki-az
display: none;

values:
interlanguage-link interwiki-azb
display: none;

values: কুষ্ঠ – Bangla

values:
interlanguage-link interwiki-bn
display: none;

values:
interlanguage-link interwiki-zh-min-nan
display: none;

values:
interlanguage-link interwiki-be
display: none;

values: Лепра – Belarusian (Taraškievica orthography)

values:
interlanguage-link interwiki-be-x-old
display: none;

values:
interlanguage-link interwiki-bg
display: none;

values: མཛེ་ནད། – Tibetan

values:
interlanguage-link interwiki-bo
display: none;

values:
https://bs.wikipedia.org/wiki/Lepra
Lepra – Bosnian
bs
bs
interlanguage-link-target

values:
interlanguage-link interwiki-bs
display: none;

values:
https://br.wikipedia.org/wiki/Lorgnez
Lorgnez – Breton
br
br
interlanguage-link-target

values:
interlanguage-link interwiki-br
display: none;

values:
https://ca.wikipedia.org/wiki/Lepra
Lepra – Catalan
ca
ca
interlanguage-link-target

values:
interlanguage-link interwiki-ca
display: none;

values:
https://cs.wikipedia.org/wiki/Lepra
Lepra – Czech
cs
cs
interlanguage-link-target

values:
interlanguage-link interwiki-cs
display: none;

values:
https://ny.wikipedia.org/wiki/Khate
Khate – Nyanja
ny
ny
interlanguage-link-target

values:
interlanguage-link interwiki-ny
display: none;

values:
interlanguage-link interwiki-sn
display: none;

values:
interlanguage-link interwiki-cy
display: none;

values:
interlanguage-link interwiki-da
display: none;

values:
https://de.wikipedia.org/wiki/Lepra
Lepra – German
de
de
interlanguage-link-target

values:
interlanguage-link interwiki-de
display: none;

values: ޖުޒާމު ބަލި – Divehi

values:
interlanguage-link interwiki-dv
display: none;

values:
https://et.wikipedia.org/wiki/Leepra
Leepra – Estonian
et
et
interlanguage-link-target

values:
interlanguage-link interwiki-et
display: none;

values: Νόσος του Χάνσεν – Greek

values:
interlanguage-link interwiki-el
display: none;

values:
https://es.wikipedia.org/wiki/Lepra
Lepra – Spanish
es
es
interlanguage-link-target

values:
https://eo.wikipedia.org/wiki/Lepro
Lepro – Esperanto
eo
eo
interlanguage-link-target

values:
interlanguage-link interwiki-eo
display: none;

values:
https://eu.wikipedia.org/wiki/Legenar
Legenar – Basque
eu
eu
interlanguage-link-target

values:
interlanguage-link interwiki-eu
display: none;

values:
interlanguage-link interwiki-fa
display: none;

values:
interlanguage-link interwiki-fr
display: none;

values:
https://ga.wikipedia.org/wiki/Lobhra
Lobhra – Irish
ga
ga
interlanguage-link-target

values:
interlanguage-link interwiki-ga
display: none;

values:
https://gl.wikipedia.org/wiki/Lepra
Lepra – Galician
gl
gl
interlanguage-link-target

values:
interlanguage-link interwiki-gl
display: none;

values: રક્તપિત – Gujarati

values:
interlanguage-link interwiki-gu
display: none;

values:
interlanguage-link interwiki-ko
display: none;

values: Բոր (հիվանդություն) – Armenian

values:
interlanguage-link interwiki-hy
display: none;

values: कुष्ठरोग – Hindi

values:
https://hr.wikipedia.org/wiki/Guba
Guba – Croatian
hr
hr
interlanguage-link-target

values:
interlanguage-link interwiki-hr
display: none;

values:
https://io.wikipedia.org/wiki/Lepro
Lepro – Ido
io
io
interlanguage-link-target

values:
interlanguage-link interwiki-io
display: none;

values:
https://ig.wikipedia.org/wiki/Ekpenta
Ekpenta – Igbo
ig
ig
interlanguage-link-target

values:
interlanguage-link interwiki-ig
display: none;

values: interlanguage-link interwiki-id badge-Q17437796 badge-featuredarticle

values:
https://xh.wikipedia.org/wiki/Iqhenqa
Iqhenqa – Xhosa
xh
xh
interlanguage-link-target

values:
interlanguage-link interwiki-xh
display: none;

values:
interlanguage-link interwiki-is
display: none;

values:
https://it.wikipedia.org/wiki/Lebbra
Lebbra – Italian
it
it
interlanguage-link-target

values:
interlanguage-link interwiki-it
display: none;

values:
interlanguage-link interwiki-he
display: none;

values: ಕುಷ್ಠರೋಗ – Kannada

values:
interlanguage-link interwiki-kn
display: none;

values:
interlanguage-link interwiki-ka
display: none;

values:
interlanguage-link interwiki-csb
display: none;

values: Алапес – Kazakh

values:
interlanguage-link interwiki-kk
display: none;

values:
https://sw.wikipedia.org/wiki/Ukoma
Ukoma – Swahili
sw
sw
interlanguage-link-target

values:
interlanguage-link interwiki-sw
display: none;

values:
interlanguage-link interwiki-ku
display: none;

values: Лепра – Kyrgyz

values:
interlanguage-link interwiki-ky
display: none;

values:
https://la.wikipedia.org/wiki/Lepra
Lepra – Latin
la
la
interlanguage-link-target

values:
interlanguage-link interwiki-la
display: none;

values:
https://lv.wikipedia.org/wiki/Lepra
Lepra – Latvian
lv
lv
interlanguage-link-target

values:
interlanguage-link interwiki-lv
display: none;

values:
https://lt.wikipedia.org/wiki/Raupsai
Raupsai – Lithuanian
lt
lt
interlanguage-link-target

values:
interlanguage-link interwiki-lt
display: none;

values:
https://ln.wikipedia.org/wiki/Maba
Maba – Lingala
ln
ln
interlanguage-link-target

values:
interlanguage-link interwiki-ln
display: none;

values:
https://hu.wikipedia.org/wiki/Lepra
Lepra – Hungarian
hu
hu
interlanguage-link-target

values:
interlanguage-link interwiki-hu
display: none;

values:
interlanguage-link interwiki-mk
display: none;

values:
interlanguage-link interwiki-ml
display: none;

values: कुष्ठरोग – Marathi

values:
interlanguage-link interwiki-mr
display: none;

values:
interlanguage-link interwiki-ms
display: none;

values:
https://min.wikipedia.org/wiki/Kusta
Kusta – Minangkabau
min
min
interlanguage-link-target

values:
interlanguage-link interwiki-min
display: none;

values:
interlanguage-link interwiki-cdo
display: none;

values:
interlanguage-link interwiki-mn
display: none;

values: အနာကြီးရောဂါ – Burmese

values:
interlanguage-link interwiki-my
display: none;

values:
https://nl.wikipedia.org/wiki/Lepra
Lepra – Dutch
nl
nl
interlanguage-link-target

values:
interlanguage-link interwiki-nl
display: none;

values: कुष्ठरोग – Nepali

values:
interlanguage-link interwiki-ne
display: none;

values: interlanguage-link interwiki-ja badge-Q17437796 badge-featuredarticle

values: interlanguage-link interwiki-no badge-Q17437798 badge-goodarticle

values:
https://nn.wikipedia.org/wiki/Lepra
Lepra – Norwegian Nynorsk
nn
nn
interlanguage-link-target

values:
interlanguage-link interwiki-nn
display: none;

values:
interlanguage-link interwiki-oc
display: none;

values: କୁଷ୍ଠ – Odia

values:
interlanguage-link interwiki-or
display: none;

values:
https://om.wikipedia.org/wiki/Qurcii
Qurcii – Oromo
om
om
interlanguage-link-target

values:
interlanguage-link interwiki-om
display: none;

values:
https://uz.wikipedia.org/wiki/Moxov
Moxov – Uzbek
uz
uz
interlanguage-link-target

values:
interlanguage-link interwiki-uz
display: none;

values:
interlanguage-link interwiki-pa
display: none;

values:
interlanguage-link interwiki-ps
display: none;

values:
https://pl.wikipedia.org/wiki/Tr%C4%85d
Trąd – Polish
pl
pl
interlanguage-link-target

values:
interlanguage-link interwiki-pl
display: none;

values:
https://pt.wikipedia.org/wiki/Lepra
Lepra – Portuguese
pt
pt
interlanguage-link-target

values:
interlanguage-link interwiki-pt
display: none;

values:
interlanguage-link interwiki-ro
display: none;

values:
interlanguage-link interwiki-qu
display: none;

values: Араҥ – Sakha

values:
interlanguage-link interwiki-sah
display: none;

values: कुष्ठरोगः – Sanskrit

values:
interlanguage-link interwiki-sa
display: none;

values:
https://sco.wikipedia.org/wiki/Liprosy
Liprosy – Scots
sco
sco
interlanguage-link-target

values:
interlanguage-link interwiki-sco
display: none;

values:
https://st.wikipedia.org/wiki/Lepera
Lepera – Southern Sotho
st
st
interlanguage-link-target

values:
interlanguage-link interwiki-st
display: none;

values:
https://nso.wikipedia.org/wiki/Lephera
Lephera – Northern Sotho
nso
nso
interlanguage-link-target

values:
interlanguage-link interwiki-nso
display: none;

values:
https://scn.wikipedia.org/wiki/Lebbra
Lebbra – Sicilian
scn
scn
interlanguage-link-target

values:
interlanguage-link interwiki-scn
display: none;

values: ලාදුරු – Sinhala

values:
interlanguage-link interwiki-si
display: none;

values:
interlanguage-link interwiki-simple
display: none;

values: ڪوڙهه – Sindhi

values:
interlanguage-link interwiki-sd
display: none;

values:
https://ss.wikipedia.org/wiki/Bulephelo
Bulephelo – Swati
ss
ss
interlanguage-link-target

values:
interlanguage-link interwiki-ss
display: none;

values:
interlanguage-link interwiki-sk
display: none;

values:
https://sl.wikipedia.org/wiki/Gobavost
Gobavost – Slovenian
sl
sl
interlanguage-link-target

values:
interlanguage-link interwiki-sl
display: none;

values:
interlanguage-link interwiki-sr
display: none;

values:
https://sh.wikipedia.org/wiki/Lepra
Lepra – Serbo-Croatian
sh
sh
interlanguage-link-target

values:
interlanguage-link interwiki-sh
display: none;

values:
interlanguage-link interwiki-su
display: none;

values:
https://fi.wikipedia.org/wiki/Lepra
Lepra – Finnish
fi
fi
interlanguage-link-target

values:
interlanguage-link interwiki-fi
display: none;

values:
https://sv.wikipedia.org/wiki/Lepra
Lepra – Swedish
sv
sv
interlanguage-link-target

values:
interlanguage-link interwiki-sv
display: none;

values:
https://tl.wikipedia.org/wiki/Ketong
Ketong – Tagalog
tl
tl
interlanguage-link-target

values:
interlanguage-link interwiki-tl
display: none;

values: தொழு நோய் – Tamil

values:
interlanguage-link interwiki-ta
display: none;

values: కుష్టు వ్యాధి – Telugu

values:
interlanguage-link interwiki-te
display: none;

values: เรื้อน – Thai

values:
interlanguage-link interwiki-th
display: none;

values:
interlanguage-link interwiki-tr
display: none;

values:
interlanguage-link interwiki-uk
display: none;

values:
interlanguage-link interwiki-vi
display: none;

values:
interlanguage-link interwiki-fiu-vro
display: none;

values:
https://war.wikipedia.org/wiki/Sanla
Sanla – Waray
war
war
interlanguage-link-target

values:
interlanguage-link interwiki-war
display: none;

values:
https://ts.wikipedia.org/wiki/Nhlokonho
Nhlokonho – Tsonga
ts
ts
interlanguage-link-target

values:
interlanguage-link interwiki-ts
display: none;

values:
interlanguage-link interwiki-yo
display: none;

values:
interlanguage-link interwiki-zh-yue
display: none;

values: कुष्ठरोग – Doteli

values:
interlanguage-link interwiki-dty
display: none;

values:
interlanguage-link interwiki-kbp
display: none;

values: All languages (initial selection from common choices by you and others)

values:
suggestions
display: none; font-size: 13px;

values: mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject page-Leprosy rootpage-Leprosy skin-vector action-view